Bio-Techne | Sustainability Performance
Provides tools and reagents for research and diagnostics in life sciences. Its products support innovation in areas like proteomics and molecular biology.
1976
United States
1,001 - 5,000 employees
Biotechnology
$1B - 10B in revenue
$25M - 100M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#3186
Overallⓘ#637
in United Statesⓘ#49
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsDigital emissionsNature and biodiversitySocial
Diversity and InclusionPay GapsExternalitiesGovernance
TargetsSDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Laggard
Laggard
Aligned
Intensity
Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Industry Benchmark
15.2
B/M 10.8
Powered by illuminem and GIST Impact
Controversy level
- BioTechne Corporation, US major life sciences research tools (R&D Systems, Novus Biologicals, Tocris, ProteinSimple), has faced multiple US class actions over alleged inadequate disclosure of postCOVID biopharma customer demand normalization following the contested 2024 sustained share price volatility amid US life sciences research tools customer demand normalization affecting US institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
4-6
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.